Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of Providers
October 04, 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development...
New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness Conference
October 02, 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development...
Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update
August 16, 2023 16:05 ET
|
Vivos Therapeutics, Inc
Operating Expenses Decreased 31% Quarter Over Quarter and 25% Year to Date,Reflecting Cost Cutting Initiatives Management to Host Conference Call Today at 6:00 pm ET LITTLETON, Colo., Aug. 16,...
Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call
August 16, 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call
August 14, 2023 17:06 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference Call
August 10, 2023 20:31 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Reports First Quarter 2023 Financial Results and Provides Operational Update
June 08, 2023 16:05 ET
|
Vivos Therapeutics, Inc
Revenue increased 6% Year-Over-Year; Operating Expenses Decreased 20% as Cost Cutting Initiatives Take Hold Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo., June 08, 2023 ...
Vivos Therapeutics Schedules Release of First Quarter 2023 Financial Results and Conference Call
June 06, 2023 16:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., June 06, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Announces Additional Strategic Initiatives Aimed at Accelerating Anticipated Timeline for Cash Flow Positive Operations
May 09, 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., May 09, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos”, “the Company”) (NASDAQ:VVOS) today announced it has implemented a broad set of initiatives aimed at improving...
Clinical Study Shows 92% of Patients Report Resolution of Migraine Headaches Using Vivos’ POD® Appliance Treatment
May 01, 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., May 01, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical technology company focused on developing and commercializing...